NEFL and amyotrophic lateral sclerosis: Neurofilaments, the neuronal cytoskeletal proteins that include light (NfL), medium (NfM), and heavy (NfH) chains, are the key biomarkers of ALS in the assessment of its progression, severity, and response to therapy [78].